GRACE
J

The Role of ctDNA Biomarker in Bladder Cancer

By GRACE FEATURING Jason Brown
By GRACE FEATURING Jason Brown
128 views
July 19, 2023
1 Comment
Login to view comments. Click here to Login

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

19:47
Janssen Oncology

All Things PSA

Feat. J. Hamilton, M. Fabrizio, M. Taha

Related Content

AUTOPLAY
15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
19:30
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Sequencing 1L Therapies in Metastatic Urothelial Carcinoma

Feat. P. Grivas
11:29
Oncology Data Advisor

Enfortumab Vedotin + Pembro for Previously Untreated Advanced Urothe…

Feat. T. Powles
12:14
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Sequencing 2L & Later Line Therapies in Metastatic Urothelial Ca…

Feat. P. Grivas
05:18
ASCO GU 2023 Conference Coverage

ASCO GU 2023: Dr. Miron and Dr. Park Discuss Kidney and Bladder Upda…

Feat. B. Miron, C. Park
21:57
International Urology Cancer Summit - IUCS

Today Biomarkers and Targets in GU Cancers

Feat. P. Rescigno
42:02
PleXus Communications

Improving Bladder Cancer Outcomes by Integrating New Knowledge Into …

Feat. M. Galsky
20:33
Arlene Siefker-Radtke

Selection and Sequencing: Emerging Therapy in Metastatic Urothelial …

11:56
PROSCA & BLADDR 2023

mUC Data With an Impact on Clinical Practice

Feat. D. De Maeseneer
21:32
ASCO 2022 Conference Coverage

ASCO 2022 Bladder Cancer Highlights

Feat. G. Sonpavde
34:37
Community Oncology Alliance

Updates in Genitourinary Malignancies

Feat. M. Lattanzi
09:30
PROSCA & BLADDR 2023

A New SOC in 1L Treatment of mUC?

Feat. I. Durán, D. Castellano
10:38
PROSCA & BLADDR 2023

Best Practices for mUC: Defining & Treating Oligometastatic Blad…

Feat. P. Hoskin
22:00
ecancer

ESMO 2023 Insights: "A Biomarker-Led Approach to Bladder Cancer…

Feat. A. Necchi, G. De Velasco, A. Siefker-Radtke, Y. Loriot
04:18
GRACE

Cisplatin-Ineligible Treatment Options for Advanced Bladder Cancer

Feat. J. Brown
08:22
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzum…

Feat. S. Tagawa
34:35
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Approaches to the Patient With Advanced Urothelial Cancer

Feat. J. Hoffman-Censits
02:11
GRACE

Future Trends for Bladder Cancer Treatment

Feat. J. Brown
19:48
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Bladder Cancer Updates From ASCO GU 2023

Feat. C. Mantia, J. Bellmunt
21:22
Yale Cancer Center

Bladder Cancer Case Study Analysis of a 70 y/o Female With Gross Hem…

Feat. M. Hurwitz, A. Cutney, J. Brito